Transcode Therapeutics Inc (RNAZ) Financials

$2.08

$0.02 (0.97%)

As on 02-Sep-2026 14:30EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.05	0.11	0.53	0.52	0.10	0.04
Gross Profit	-0.05	-0.11	-0.53	-0.52	-0.10	-0.04
Operating Expenses	25.14	27.98	15.13	18.90	18.57	6.11
Operating Profit (EBIT)	-25.16	-27.98	-15.66	-19.42	-18.67	-6.15
Other Income	--	--	--	--	--	--
Profit before Tax	-42.38	-34.44	-16.75	-18.55	-17.56	-6.84
Provision for Tax	0.23	0.23	-16,785.57	0.00	17.56	0.10
Profit after Tax (Net Income)	-42.78	-34.66	-16.75	-18.55	-17.56	-6.84
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-17.56	-6.84

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	138.36	10.34	-2.02	1.64	3.24	20.40
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.25	148.57	6.54	0.04	4.35	0.03
Current Liabilities	5.40	3.49	2.77	3.49	4.35	2.53
Total Liabilities	156.41	162.40	7.29	5.17	7.59	22.94

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	140.37	140.41	0.20	0.71	0.21	0.21
Current Assets	10.64	21.98	7.09	4.46	7.38	22.73
Total Assets	161.65	162.40	7.29	5.17	7.59	22.94
Total Debt*	0.65	--	0.04	0.45	--	--
Net Current Assets	--	18.49	4.32	0.96	3.03	20.20

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-19.52	-13.34	-18.07	-15.76	-5.27
Cash Flow from Investing Activities	--	0.00	-0.02	-0.04	-0.10	-0.25
Cash from Financing Activities	--	31.52	16.40	15.91	0.01	25.52
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-47.03	-37.80	-47.05	-976.11	-575.90	-422.43
Cash EPS ($)	--	-37.67	-45.55	-954.74	-572.67	-419.81
Adjusted Book Value ($)	--	11.27	--	86.36	106.25	1,259.53
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-21.28	-37.45	-951.29	-516.80	-325.12
Free Cash Flow per Share ($)	--	-21.29	-37.51	-953.17	-520.11	-340.85

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-829.71	-30,204.65	-695.64	-148.57	-71.72
ROE (%)	-29.48	-833.53	8,866.96	-759.85	-148.57	-80.53
ROA (%)	-49.90	-40.85	-268.85	-290.74	-115.08	-57.04
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-55.02	-105.81	9.53	-5.27	-160.29	-364.42
Net Profit Growth (%)	-103.39	-106.87	9.66	-5.59	-156.67	-191.97
EPS Growth (%)	46.80	0.20	0.95	-0.69	-0.36	0.96
Book Value Growth (%)	1,902.02	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.18	-0.07	0.00	0.00	-0.01
Price / Book Value	2.83	0.61	-0.59	0.00	0.01	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.59	0.34	0.28	0.13	0.28	3.10
Close Price ($)	6.21	6.83	94.36	6,098.40	497,481.60	1,877,568.00
High Price ($)	20.99	468.44	206,976.00	790,944.00	2,313,696.00	5,174,400.00
Low Price ($)	3.82	6.08	89.88	5,263.10	207,715.20	7,392.00
Market Cap ($ Cr)	2.41	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	-0.02	0.27	--	--
Short term debt to equity ratio	0.00	--	-0.02	0.25	--	0.10
Current Ratio	1.97	6.29	2.56	1.28	1.70	8.97
Quick Ratio	1.97	--	--	--	1.57	--
Interest Coverage	-6,015.00	-5,203.81	-623.88	-330.78	-1.00	-70.98

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	391.82	2,053.31	--
Payable days	--	9,109.85	1,675.81	2,281.88	11,373.81	10,257.91
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.